BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37458894)

  • 21. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.
    Sardanelli F; Aase HS; Álvarez M; Azavedo E; Baarslag HJ; Balleyguier C; Baltzer PA; Beslagic V; Bick U; Bogdanovic-Stojanovic D; Briediene R; Brkljacic B; Camps Herrero J; Colin C; Cornford E; Danes J; de Geer G; Esen G; Evans A; Fuchsjaeger MH; Gilbert FJ; Graf O; Hargaden G; Helbich TH; Heywang-Köbrunner SH; Ivanov V; Jónsson Á; Kuhl CK; Lisencu EC; Luczynska E; Mann RM; Marques JC; Martincich L; Mortier M; Müller-Schimpfle M; Ormandi K; Panizza P; Pediconi F; Pijnappel RM; Pinker K; Rissanen T; Rotaru N; Saguatti G; Sella T; Slobodníková J; Talk M; Taourel P; Trimboli RM; Vejborg I; Vourtsis A; Forrai G
    Eur Radiol; 2017 Jul; 27(7):2737-2743. PubMed ID: 27807699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of Population-Based Service Screening with Mammography for Women Aged 70-74 Years in Sweden.
    Mao Z; Nyström L; Jonsson H
    Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2149-2156. PubMed ID: 32856607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nonparticipation at previous screening rounds on the characteristics of screen-detected breast cancers.
    Duijm LEM; Broeders MJM; Setz-Pels W; van Breest Smallenburg V; van Beek HC; Donkers-van Rossum AB; Slob MJ; Kuipers TP; Mann RM; Voogd AC
    Eur J Radiol; 2022 Sep; 154():110391. PubMed ID: 35679699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
    Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
    Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
    Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
    Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Readmissions and complications in breast ductal carcinoma in situ: A retrospective study comparing screen- and non-screen-detected patients.
    Politi J; Sala M; Domingo L; Vernet-Tomas M; Román M; Macià F; Castells X
    Womens Health (Lond); 2020; 16():1745506520965899. PubMed ID: 33076785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.
    Conant EF; Barlow WE; Herschorn SD; Weaver DL; Beaber EF; Tosteson ANA; Haas JS; Lowry KP; Stout NK; Trentham-Dietz A; diFlorio-Alexander RM; Li CI; Schnall MD; Onega T; Sprague BL;
    JAMA Oncol; 2019 May; 5(5):635-642. PubMed ID: 30816931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of breast cancers detected by screening mammography in Taiwan: a single institute's experience.
    Han HJ; Chu YC; Wang J; Lai YC; Tseng LM; Huang CC
    BMC Womens Health; 2023 Jun; 23(1):330. PubMed ID: 37344800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading.
    Martiniussen MA; Sagstad S; Larsen M; Larsen ASF; Hovda T; Lee CI; Hofvind S
    Eur Radiol; 2022 Sep; 32(9):5974-5985. PubMed ID: 35364710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012.
    White A; Miller J; Royalty J; Ryerson AB; Benard V; Helsel W; Kammerer W
    Cancer Causes Control; 2015 May; 26(5):723-32. PubMed ID: 25809209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extending Screening in "Elderly" Patients: Should We Consider a Selective Approach?
    Ip EC; Cohen-Hallaleh RB; Ng AK
    Clin Breast Cancer; 2020 Oct; 20(5):377-381. PubMed ID: 32402812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of screening on breast cancer detection. Retrospective comparative study of two periods ten years apart.
    Aubard Y; Genet D; Eyraud JL; Clavère P; Tubiana-Mathieu N; Philippe HJ
    Eur J Gynaecol Oncol; 2002; 23(1):37-41. PubMed ID: 11876389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why Start Now? Retrospective Study Evaluating Baseline Screening Mammography in Patients Age 60 and Older.
    Chieh AY; Willis JG; Carroll CM; Mobley AA; Li Y; Li M; Woodard S
    Curr Probl Diagn Radiol; 2024; 53(1):62-67. PubMed ID: 37704485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36-45 years) breast cancer patients.
    Szollár A; Újhelyi M; Polgár C; Oláh E; Pukancsik D; Rubovszky G; Udvarhelyi N; Kovács T; Sávolt Á; Kenessey I; Mátrai Z
    Eur J Surg Oncol; 2019 Nov; 45(11):2009-2015. PubMed ID: 31189512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of clinicopathological characteristics and long-term survival outcomes between symptomatic and screen-detected breast cancer in Japanese women.
    Inari H; Shimizu S; Suganuma N; Yoshida T; Nakayama H; Yamanaka T; Yamanaka A; Rino Y; Masuda M
    Breast Cancer; 2017 Jan; 24(1):98-103. PubMed ID: 26868519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study of the use and effects of screening mammography in women aged 70 and older.
    Vacek PM; Skelly JM
    J Am Geriatr Soc; 2015 Jan; 63(1):1-7. PubMed ID: 25537022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.
    Prummel MV; Done SJ; Muradali D; Majpruz V; Brown P; Jiang H; Shumak RS; Yaffe MJ; Holloway CM; Chiarelli AM
    Breast Cancer Res Treat; 2014 Sep; 147(2):389-99. PubMed ID: 25108740
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.